Prognostic Significance of P53 Histochemistry and DNA Histogram Parameters in Head and Neck Malignancies
Overview
Authors
Affiliations
Background: The aim of the study was to determine the role of quantitative pathological parameters in prognosis of head and neck malignancies.
Materials And Methods: 51 head and neck squamous cell carcinoma patients were examined for mutant p53 gene expression (45 out of 51 patients) by immunohistochemistry and for cellular DNA-content (44 out of 51 patients) using digital picture analyzer. Statistical analysis was performed using BMDP package.
Results: No correlation with prognosis was found for age, sex, localization, T-classification and therapy. There was significant relationship between N-status and overall survival (p = 0.0008). No correlation was found with overall and disease-free survival for either histologic type or grading. P53: No significant correlation was detected with overall survival. A relationship was found between mutant p53 and metastasis-free time (p = 0.06). Ploidy: There were no significant differences between aneuploid and euploid tumors for either disease-free or overall survival. Synthetic (S)-phase fraction: A correlation was found for both survival rates (p = 0.029) and metastasis-free time (p = 0.05). Polyploid fraction (PF): correlation was shown for both overall survival (p = 0.0128) and metastasis-free time (p = 0.0038).
Conclusion: There is correlation between p53 overexpression and metastatic potential and there is a significant relationship between SPF and PF value and prognosis (metastasis-free and overall survival) of head and neck cancer.
Szentkuti G, Danos K, Brauswetter D, Kiszner G, Krenacs T, Csako L Pathol Oncol Res. 2014; 21(3):643-50.
PMID: 25547827 DOI: 10.1007/s12253-014-9869-4.
Melegh Z, Csernak E, Toth E, Veleczki Z, Magyarosy E, Nagy K Virchows Arch. 2005; 446(5):517-24.
PMID: 15827757 DOI: 10.1007/s00428-005-1204-8.
Qin L, Tang Z J Cancer Res Clin Oncol. 2004; 130(9):497-513.
PMID: 15205947 DOI: 10.1007/s00432-004-0572-9.
Qin L, Tang Z, Ma Z, Wu Z, Zhou X, Ye Q World J Gastroenterol. 2002; 8(3):459-63.
PMID: 12046070 PMC: 4656421. DOI: 10.3748/wjg.v8.i3.459.
The prognostic molecular markers in hepatocellular carcinoma.
Qin L, Tang Z World J Gastroenterol. 2002; 8(3):385-92.
PMID: 12046056 PMC: 4656407. DOI: 10.3748/wjg.v8.i3.385.